Cardiogenesis Transmyocardial Revascularization Registry (ANGINA RELIEF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
Information provided by (Responsible Party):
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. Identifier:
First received: April 5, 2013
Last updated: June 17, 2014
Last verified: June 2014

The objectives of the registry are as follows:

  • Track "real world" performance outcomes and physician experience using the Cardiogenesis Laser System;
  • Further define the disease characteristics of the population being treated;
  • Examine transmyocardial revascularization (TMR) usage characteristics and 30-day outcomes;
  • Further assess the 30-day postoperative risk factors for adverse events. To limit the potential for bias, all patients eligible for TMR treatment who meet the Inclusion and Exclusion Criteria are to be offered the opportunity to enroll in the study at participating centers.

Class IV Angina

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Days
Official Title: A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG Laser System Transmyocardial Revascularization for Angina Reduction

Resource links provided by NLM:

Further study details as provided by Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.:

Primary Outcome Measures:
  • All cause mortality [ Time Frame: 30 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Major adverse cardiovascular events (MACE) rate, defined as the incidence of cardiac-related death, myocardial infarction (Q-wave and non Q-wave), congestive heart failure, cerebrovascular accident, and serious arrhythmia [ Time Frame: 30 days ] [ Designated as safety issue: No ]
  • Angina class [ Time Frame: 30 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 1000
Study Start Date: May 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients who meet the eligibility criteria and undergo TMR at the selected centers will be provided an opportunity to participate.


Inclusion Criteria:

  • Class IV angina (according to Canadian Cardiovascular Society Angina Scale)
  • Patients with regions of myocardium in the distal two-thirds of the left ventricle with reversible ischemia and who are not eligible for direct coronary revascularization (e.g., CABG or PTCA)

Exclusion Criteria:

  • Age less than18 years
  • Severely unstable angina (un-weanable from intravenous anti-anginals for 48-hours)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01827319

Contact: Scott Capps, MS 770-419-3355

United States, Arizona
University of Arizona Recruiting
Tuscon, Arizona, United States, 85722
Principal Investigator: Zain Khalpey, MD         
United States, California
California Cardiac Surgeons Recruiting
Bakersfield, California, United States, 93301
Principal Investigator: Eric Peck, MD         
The Vo Group Recruiting
Fountain Valley, California, United States, 92708
Principal Investigator: Quang Vo, MD         
Hurwitz & Roberts Med Corp Recruiting
Glendale, California, United States, 91204
Principal Investigator: Ashraf Osmand, MD         
Advanced Cardiothoracic Surgery Medical Group Recruiting
Los Angeles, California, United States, 90017
Principal Investigator: Ali Gheissari, MD         
Soltero & Yasuda Associates Cardiothoracic & Vascular Medical Group Recruiting
Northridge, California, United States, 91325
Principal Investigator: Azmi Atiya, MD         
Joseph W. Wilson, MD, Inc. Recruiting
Rancho Mirage, California, United States, 92270
Principal Investigator: Joseph W. Wilson, MD         
United States, Florida
Broward Health Medical Center Recruiting
Ft. Lauderdale, Florida, United States, 33316
Principal Investigator: Frank Catinella, MD         
Cardiothoracic and Vascular Surgical Associates Recruiting
Jacksonville, Florida, United States, 32207
Principal Investigator: Mark Mostovych, MD         
Cardiothoracic and Vascular Surgical Associates Recruiting
Jacksonville, Florida, United States, 32207
Principal Investigator: Robert Still, MD         
Coastal Cardiovascular and Thoracic Associates, PA Recruiting
Ormond Beach, Florida, United States, 32174
Principal Investigator: William H Johnson, MD         
United States, Georgia
Georgia Health Sciences University Research Institute, Inc. Recruiting
Augusta, Georgia, United States, 30912-
Principal Investigator: Vinayak Kamath, MD         
United States, Kentucky
Owensboro Health, Inc. Recruiting
Owensboro, Kentucky, United States, 42303
Principal Investigator: Sohit Khanna, MD         
Principal Investigator: Robert Adams, MD         
Regional Heart & Lung Surgery Recruiting
Paducah, Kentucky, United States, 42003
Principal Investigator: James O'Rouke, MD         
United States, Missouri
Saint Luke's Hospital Recruiting
Kansas City, Missouri, United States, 64111
Principal Investigator: Keith Allen, MD         
United States, New York
The Feinstein Institute for Medical Research Recruiting
New York, New York, United States, 10075
Principal Investigator: Nirav C Patel, MD         
United States, Oklahoma
Oklahoma Heart Hospital Recruiting
Oklahoma City, Oklahoma, United States, 73120
Principal Investigator: John Randolph, MD         
United States, Tennessee
East Tennessee Cardiovascular Surgery Group Recruiting
Knoxville, Tennessee, United States, 37923
Principal Investigator: Thomas Pollard, MD         
Tristar Cardiovascular Surgery Recruiting
Nashville, Tennessee, United States, 37203
Principal Investigator: V. Seenu Reddy, MD         
United States, Texas
Cardiopulmonary Research Science and Technology Institute Recruiting
Dallas, Texas, United States, 75230
Principal Investigator: Tung Cai, MD         
Sponsors and Collaborators
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
Study Director: Scott Capps, MS CryoLife, Inc.
  More Information

No publications provided

Responsible Party: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. Identifier: NCT01827319     History of Changes
Other Study ID Numbers: TMR1201.001-M
Study First Received: April 5, 2013
Last Updated: June 17, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.:
Transmyocardial revascularization processed this record on April 16, 2015